Related Experiment Video
Updated: Sep 14, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Procedural and Clinical Outcomes of Coronary Intravascular Lithotripsy in Patients With Impaired Renal Function: A
Akshay A S Phagu1, Martijn J H van Oort1, Federico Oliveri1
1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Insights
Intravascular lithotripsy (IVL)-assisted percutaneous coronary intervention (PCI) shows similar procedural and major adverse cardiovascular event (MACE) rates in patients with and without renal insufficiency. However, chronic kidney disease is associated with higher mortality post-IVL PCI.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Chronic kidney disease (CKD) is common in patients undergoing percutaneous coronary intervention (PCI).
- The impact of renal insufficiency on outcomes after intravascular lithotripsy (IVL)-assisted PCI is not well understood.
- This study investigates IVL-assisted PCI outcomes in patients with varying degrees of renal function.
Purpose of the Study:
- To evaluate procedural and long-term outcomes of IVL-assisted PCI in patients with renal insufficiency compared to those with normal renal function.
- To identify predictors of mortality in patients undergoing IVL-assisted PCI.
Main Methods:
- Retrospective analysis of 558 patients from the BENELUX-IVL registry (May 2019-September 2024).
- Renal insufficiency defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m².
- Primary endpoint: major adverse cardiovascular events (MACE) at one and two years. Secondary endpoints: procedural success, all-cause mortality.
Main Results:
- No significant difference in one-year MACE (13.3% vs. 10.9%, p=0.80) or two-year MACE (5.6% vs. 2.8%, p=0.46) between groups.
- Procedural success rates were similar (88.6% vs. 88.7%, p=0.97).
- All-cause mortality was significantly higher in patients with renal insufficiency (18.2% vs. 11.5%, p=0.03).
- Lower eGFR was an independent predictor of mortality (OR 0.98; 95% CI 0.97-1.00; p=0.020).
Conclusions:
- IVL-assisted PCI demonstrates comparable procedural success and MACE rates irrespective of renal function.
- Patients with renal insufficiency undergoing IVL-assisted PCI face a significantly higher risk of all-cause mortality.
- Renal function, specifically eGFR, is a critical factor influencing long-term survival after IVL-assisted PCI.
Abstract:
Chronic kidney disease (CKD) is a prevalent comorbidity in patients undergoing percutaneous coronary intervention (PCI), yet its impact on outcomes following intravascular lithotripsy (IVL) remains insufficiently studied. This study evaluated procedural and long-term outcomes of IVL-assisted PCI in patients with renal insufficiency compared to those with normal renal function. From the BENELUX-IVL registry (May 2019-September 2024), 558 patients were included in a retrospective multicenter analysis. Renal insufficiency was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m² using the CKD-EPI formula. The primary endpoint was major adverse cardiovascular events (MACE) at one and two years of follow-up. Secondary endpoints included procedural, device, and technical success, as well as all-cause mortality. Multivariable logistic regression was used to identify independent predictors of mortality. A total of 586 lesions were treated in 558 patients: 190 (32.4%) with renal insufficiency and 396 (67.6%) with normal renal function. One-year MACE occurred in 14 (13.3%) versus 28 (10.9%) patients (p = 0.80), and between year one and two in 4 (5.6%) versus 5 (2.8%) patients (p = 0.46). Procedural success was similar between groups (88.6% versus 88.7%; p = 0.97). All-cause mortality was higher in the renal insufficiency group (n = 32, 18.2% versus n = 44, 11.5%; p = 0.03). On multivariable analysis, eGFR was independently associated with mortality (OR 0.98; 95% CI 0.97-1.00; p = 0.020). In conclusion, IVL-assisted PCI resulted in similar procedural and MACE outcomes regardless of renal function, although mortality was significantly higher in patients with renal insufficiency.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Urinary Tract Calculi III: Medical Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction

